Sean A. McCarthy, President and CEO at CytomX Therapeutics, Inc. (CTMX), sold 36,000 shares at $15.00 ($540K) on 2020-05-12, disclosed to the SEC on 2020-05-14.
Open-market sale of $540k CTMX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CTMX | SELL | 2025-11-10 | $924K | — | Filing → |
| CTMX | SELL | 2025-06-17 | $299K | — | Filing → |
| CTMX | SELL | 2025-03-20 | $23K | — | Filing → |